Literature DB >> 20119930

Ventricular function and all-cause mortality in chronic kidney disease patients with angiographic coronary artery disease.

I-Wen Wu1, Ming-Jui Hung, Yung-Chang Chen, Heng-Jung Hsu, Wen-Jin Cherng, Chee-Jen Chang, Mai-Szu Wu.   

Abstract

BACKGROUND: Coronary artery disease (CAD) and chronic kidney disease (CKD) lead to high morbidity and mortality rates. Traditional and nontraditional risk factors, hypertension, fluid overloading and anemia can lead to myocardial ischemia, chamber hypertrophy and dilatation, and low left ventricular ejection fraction (LVEF) in CKD patients. The angiographic feature, ventriculographic LVEF and its relationship to all-cause mortality are unclear in patients with different stages of CKD who are not yet on dialysis.
METHODS: This retrospective study involved 980 CKD patients with suspected myocardial ischemia who underwent coronary angiography from 1995 to 2004. Demographic, clinical data and ventriculographic LVEF were assessed. Risk estimations for mortality were performed using Cox proportional hazard regression models.
RESULTS: Of the CKD patients, 445 (45.4%) had angiographic CAD. Their hemoglobin, body mass index (BMI) and LVEF values decreased with decrease in eGFR. Using Cox proportional hazard regression analysis, low LVEF was independently associated with CKD after adjustment for age, sex, diabetes, hypertension, BMI, hemoglobin and the presence of CAD. Significant independent prognostic factors for mortality included diabetes (hazard ratio [HR] = 2.946; 95% confidence interval [95% CI], 1.185-7.322), BMI (HR=0.864; 95% CI, 0.757-0.985), hemoglobin (HR=0.742; 95% CI, 0.594-0.928) and LVEF (HR=0.944; 95% CI, 0.918-0.970). Low LVEF was the only independent significant prognostic factor in CKD patients with angiographic CAD (HR=0.957; 95% CI, 0.918-0.996).
CONCLUSION: LVEF reduction was independently associated with CKD. Low LVEF was an independent predictor of mortality in CKD patients regardless of the presence of angiographic CAD.

Entities:  

Mesh:

Year:  2010        PMID: 20119930

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  13 in total

Review 1.  Atherosclerosis in CKD: differences from the general population.

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.

Authors:  Leila R Zelnick; Ronit Katz; Bessie A Young; Adolfo Correa; Bryan R Kestenbaum; Ian H de Boer; Nisha Bansal
Journal:  Am J Kidney Dis       Date:  2017-01-28       Impact factor: 8.860

3.  A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study.

Authors:  Nisha Bansal; Martin Keane; Patrice Delafontaine; Daniel Dries; Elyse Foster; Crystal A Gadegbeku; Alan S Go; L Lee Hamm; John W Kusek; Akinlolu O Ojo; Mahboob Rahman; Kaixiang Tao; Jackson T Wright; Dawei Xie; Chi-yuan Hsu
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 8.237

4.  High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Nisha Bansal; Amanda Hyre Anderson; Wei Yang; Robert H Christenson; Christopher R deFilippi; Rajat Deo; Daniel L Dries; Alan S Go; Jiang He; John W Kusek; James P Lash; Dominic Raj; Sylvia Rosas; Myles Wolf; Xiaoming Zhang; Michael G Shlipak; Harold I Feldman
Journal:  J Am Soc Nephrol       Date:  2014-10-02       Impact factor: 10.121

5.  Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients.

Authors:  Michiaki Higashitani; Fumiaki Mori; Norihiro Yamada; Hiroyuki Arashi; Asako Kojika; Hiromi Hoshi; Yuichiro Minami; Junichi Yamaguchi; Takao Yamauchi; Atsushi Takagi; Hiroshi Ogawa; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2011-01-26       Impact factor: 2.037

6.  Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study.

Authors:  Nisha Bansal; Jason Roy; Hsiang-Yu Chen; Rajat Deo; Mirela Dobre; Michael J Fischer; Elyse Foster; Alan S Go; Jiang He; Martin G Keane; John W Kusek; Emile Mohler; Sankar D Navaneethan; Mahboob Rahman; Chi-Yuan Hsu
Journal:  Am J Kidney Dis       Date:  2018-05-18       Impact factor: 8.860

Review 7.  Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.

Authors:  Nisha Bansal
Journal:  Semin Nephrol       Date:  2017-03       Impact factor: 5.299

8.  Cardiac function is preserved following 4 weeks of voluntary wheel running in a rodent model of chronic kidney disease.

Authors:  James M Kuczmarski; Christopher R Martens; Jahyun Kim; Shannon L Lennon-Edwards; David G Edwards
Journal:  J Appl Physiol (1985)       Date:  2014-07-24

9.  Exploring the relation between mortality and left ventricular structure and function in stable hemodialysis treated patients, a longitudinal multicenter cohort study.

Authors:  Lazar A Chisavu; Adrian Apostol; Gheorghe N Pop; Viviana Ivan; Oana Schiller; Flaviu Bob; Luciana Marc; Adelina Mihaescu; Florica Gadalean; Iulia Grosu; Bogdan Timar; Adalbert Schiller
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

10.  Echocardiographic markers of left ventricular dysfunction among men with uncontrolled hypertension and stage 3 chronic kidney disease.

Authors:  Radosław Grabysa; Zofia Wańkowicz
Journal:  Med Sci Monit       Date:  2013-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.